Johnson & Johnson (NYSE: JNJ) has kicked off construction on a $2 billion biologics manufacturing facility in Eastern North ...

The pharmaceutical ingredients manufacturer will conduct three rounds of job cuts starting in May and continuing through 2026 ...

North Carolina’s total incentives for the project ... And the region overall supports production sites from Thermo Fisher Scientific, Merck, Novo Nordisk, Grifols, Pfizer and Catalent.

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Cervical cancer is one of the most preventable cancers, although recent research suggests that the United States is ...

After Trump threatened 25% tariffs on pharma imports, J&J became the latest pharma company to announce investments in the U.S.

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Drugmakers are urging the Trump administration and European Union officials to exempt medical goods from widening tariff wars, hoping to avert an ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.